An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis

Andrea Necchi, Patrizia Giannatempo, Daniele Raggi, Luigi Mariani, Maurizio Colecchia, Elena Farè, Francesco Monopoli, Giuseppina Calareso, Siraj M. Ali, Jeffrey S. Ross, Jon H. Chung, Roberto Salvioni

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)201-203
Number of pages3
JournalEuropean Urology
Issue number1
Publication statusPublished - Jan 2019

ASJC Scopus subject areas

  • Urology

Cite this